MedPath

Actos

ACTOS (pioglitazone hydrochloride) Tablets

Approved
Approval ID

fd156adc-3174-44da-bff7-eeaef5983f18

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 1, 2010

Manufacturers
FDA

Rebel Distributors Corp.

DUNS: 118802834

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

pioglitazone hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-148
Application NumberNDA021073
Product Classification
M
Marketing Category
C73594
G
Generic Name
pioglitazone hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 1, 2009
FDA Product Classification

INGREDIENTS (1)

pioglitazone hydrochlorideActive
Quantity: 30 mg in 1 1
Code: JQT35NPK6C
Classification: ACTIB

pioglitazone hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-147
Application NumberNDA021073
Product Classification
M
Marketing Category
C73594
G
Generic Name
pioglitazone hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 1, 2009
FDA Product Classification

INGREDIENTS (1)

pioglitazone hydrochlorideActive
Quantity: 15 mg in 1 1
Code: JQT35NPK6C
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Actos - FDA Drug Approval Details